Home > Journals > Panminerva Medica > Past Issues > Articles online first > Panminerva Medica 2020 Nov 09

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

 

Panminerva Medica 2020 Nov 09

DOI: 10.23736/S0031-0808.20.04188-9

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Breakthrough healthcare technologies in the COVID-19 era: a unique opportunity for cardiovascular practitioners and patients

Raffaele NUDI 1, 2, Marco CAMPAGNA 3, Alessio PARMA 3, Andrea NUDI 4, 5, Giuseppe BIONDI-ZOCCAI 6, 7

1 Service of Hybrid Cardio Imaging, Madonna della Fiducia Clinic, Rome, Italy; 2 Ostia Radiologica, Rome, Italy; 3 Finsa, Torino, Italy; 4 Replycare, Rome, Italy; 5 ETISAN, Rome, Italy; 6 Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; 7 Mediterranea Cardiocentro, Napoli, Italy


PDF


INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic, caused by symptomatic severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection, has wreaked havoc globally, challenging the healthcare, economical, technological and social status quo of developing but also developed countries. For instance, the COVID-19 scare has reduced timely hospital admissions for ST-elevation myocardial infarction in Europe and the USA, causing unnecessary deaths and disabilities. While the emergency is still ongoing, enough efforts have been put to study and tackle this condition such that a comprehensive perspective and synthesis on the potential role of breakthrough healthcare technologies is possible. Indeed, current state-of-the-art information technologies can provide a unique opportunity to adapt and adjust to the current healthcare needs associated with COVID-19, either directly or indirectly, and in particular those of cardiovascular patients and practitioners.
EVIDENCE ACQUISITION: We searched several biomedical databases, websites and social media, including PubMed, Medscape, and Twitter, for smartcare approaches suitable for application in the COVID-19 pandemic.
EVIDENCE SYNTHESIS: We retrieved details on several promising avenues for present and future healthcare technologies, capable of substantially reduce the mortality, morbidity, and resource use burden of COVID-19 as well as that of cardiovascular disease. In particular, we have found data supporting the importance of data sharing, model sharing, preprint archiving, social media, medical case sharing, distance learning and continuous medical education, smartphone apps, telemedicine, robotics, big data analysis, machine learning, and deep learning, with the ultimate goal of optimization of individual prevention, diagnosis, tracing, risk-stratification, treatment and rehabilitation.
CONCLUSIONS: We are confident that refinement and command of smartcare technologies will prove extremely beneficial in the short-term, but also dramatically reshape cardiovascular practice and healthcare delivery in the long-term future.


KEY WORDS: Cardiovascular disease; Cardiovascular medicine; COVID-19; Prevention; Technology

top of page